Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,057,000 | 6,545,000 | 5,623,000 | 3,382,509 | 2,004,380 |
| Marketable Securities | 277,000 | 397,000 | 391,000 | 1,154,228 | 1,034,601 |
| Inventories | 3,837,000 | 4,064,000 | 4,056,000 | 3,064,832 | 2,436,187 |
| Other current assets | 5,865,000 | 6,564,000 | 7,199,000 | 6,037,890 | 5,289,379 |
| TOTAL | $16,036,000 | $17,570,000 | $17,269,000 | $13,639,458 | $10,988,617 |
| Non-Current Assets | |||||
| PPE Net | 9,045,000 | 9,374,000 | 9,678,000 | 7,828,481 | 6,927,795 |
| Intangibles | 12,138,000 | 11,544,000 | 7,970,000 | 5,832,156 | 4,050,103 |
| Other Non-Current Assets | 5,011,000 | 4,374,000 | 4,476,000 | 3,733,467 | 3,578,485 |
| TOTAL | $26,194,000 | $25,292,000 | $22,124,000 | $17,394,104 | $14,556,383 |
| Total Assets | $42,230,000 | $42,862,000 | $39,393,000 | $31,033,562 | $25,545,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 291,000 | 1,471,000 | 956,000 | 3,507,563 | 717,636 |
| Accounts payable and accrued liabilities | 6,888,000 | 6,772,000 | 6,075,000 | 4,866,013 | 864,635 |
| Other current liabilities | 188,000 | 168,000 | 752,000 | 1,719,493 | 2,809,297 |
| TOTAL | $12,794,000 | $12,118,000 | $10,017,000 | $10,355,278 | $7,262,624 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,809,000 | 14,786,000 | 15,231,000 | 6,990,922 | 4,673,314 |
| Other Non-Current Liabilities | 3,317,000 | 3,834,000 | 4,726,000 | 2,489,482 | 3,010,909 |
| TOTAL | $19,691,000 | $20,002,000 | $21,058,000 | $10,758,678 | $8,637,668 |
| Total Liabilities | $32,485,000 | $32,120,000 | $31,075,000 | $21,113,956 | $15,900,292 |
| Shareholders' Equity | |||||
| Common Shares | 1,418,000 | 1,416,000 | 1,415,000 | 1,504,682 | 1,497,543 |
| Retained earnings | 4,779,000 | 6,321,000 | 4,622,000 | 6,481,630 | 6,963,013 |
| Other shareholders' equity | 1,262,000 | 900,000 | 568,000 | 359,026 | 64,822 |
| TOTAL | $8,887,000 | $10,005,000 | $7,931,000 | $9,612,518 | $9,382,867 |
| Total Liabilities And Equity | $41,372,000 | $42,125,000 | $39,006,000 | $30,726,474 | $25,283,159 |